EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Vagal nerve stimulation for the management of long COVID symptoms

Malik W Z Khan, Muhammad Ahmad, Salma Qudrat, Fatma Afridi, Najia Ali Khan, Zain Afridi, Fahad, Touba Azeem, Jibran Ikram

Infectious Medicine · 2024-12 · 3 (4) · 100149

DOI: 10.1016/j.imj.2024.100149 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Infectious Medicine, 2024-12. Verfasst von Malik W Z Khan und 8 weiteren Autor:innen. Beteiligte Einrichtung: Yale University School of Medicine, New Haven, Connecticut 06520, USA. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This review investigates the therapeutic potential of vagal nerve stimulation (VNS) in managing long COVID, a condition marked by persistent symptoms following acute SARS-CoV-2 infection. Long COVID manifests as ongoing fatigue, cognitive impairment, and autonomic dysfunction, hypothesized to arise from sustained inflammatory and neurological dysregulation. The vagus nerve, central to modulating systemic inflammation and autonomic homeostasis, represents a promising therapeutic target for symptom alleviation through VNS. A comprehensive literature search was conducted across PubMed, Scopus, and Web of Science to identify studies evaluating VNS in the context of long COVID. Preliminary evidence from small-scale pilot studies suggests VNS may attenuate systemic inflammation through activation of the cholinergic anti-inflammatory pathway (CAP), thus restoring autonomic balance and ameliorating symptoms such as fatigue, cognitive dysfunction, and anxiety. In targeting the inflammatory cascade that underlies both acute COVID-19 pathophysiology and its prolonged sequelae, VNS holds potential as an innovative intervention for persistent post-viral symptoms. While these initial findings indicate promise, current data remain limited in scope and robustness, underscoring the need for larger, controlled trials to validate the efficacy and mechanisms of VNS in long COVID management. Establishing a clearer understanding of VNS's impact on inflammation and autonomic regulation in this context is crucial to inform clinical guidelines and therapeutic strategies for long COVID, potentially offering a targeted approach for mitigating this disabling condition.

Schlagwörter

Stichwörter der Autor:innen

COVID-19Invasive vagal nerve stimulationLong COVIDNon-invasive vagal nerve stimulationTranscutaneous vagal nerve stimulation

Autor:innen und Institutionen

  • Yale University School of Medicine, New Haven, Connecticut 06520, USA.
  • Khyber Medical College, Peshawar 25120, Khyber Pakhtunkhwa, Pakistan.
  • Department of Cardiology, Cleveland Clinic Foundation, Ohio 44195, USA.

Zitieren

APA

Khan, M. W. Z., Ahmad, M., Qudrat, S., Afridi, F., Khan, N. A., Afridi, Z., Fahad, Azeem, T., & Ikram, J. (2024). Vagal nerve stimulation for the management of long COVID symptoms. Infectious Medicine, 3(4), 100149. https://doi.org/10.1016/j.imj.2024.100149

Vancouver

Khan MWZ, Ahmad M, Qudrat S, Afridi F, Khan NA, Afridi Z, et al. Vagal nerve stimulation for the management of long COVID symptoms. Infectious Medicine. 2024;3(4):100149. doi:10.1016/j.imj.2024.100149

BibTeX
@article{Khan2024,
  author = {Khan, Malik W Z and Ahmad, Muhammad and Qudrat, Salma and Afridi, Fatma and Khan, Najia Ali and Afridi, Zain and Fahad and Azeem, Touba and Ikram, Jibran},
  title = {Vagal nerve stimulation for the management of long COVID symptoms},
  journal = {Infectious Medicine},
  year = {2024},
  volume = {3},
  number = {4},
  pages = {100149},
  doi = {10.1016/j.imj.2024.100149}
}
Kostenlos starten →